Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Generex Biotechnology Corp. (GNBTQ) had Weighted-Average Shares Outstanding (Diluted) of 140.41M for the most recently reported fiscal quarter, ending 2021-04-30.
| Income Statement Financials | |
$0.02M |
|
$9.22M |
|
$0.07M |
|
$-0.05M |
|
$6.38M |
|
$-6.36M |
|
$14.85M |
|
$8.49M |
|
$8.49M |
|
$8.49M |
|
$8.49M |
|
$8.49M |
|
$8.49M |
|
$-6.36M |
|
$-6.10M |
|
114.61M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
140.41M |
$0.08 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$2.47M |
|
$0.12M |
|
$43.45M |
|
$45.92M |
|
$64.07M |
|
$0.55M |
|
$25.93M |
|
$90.01M |
|
$-44.08M |
|
$-87.25M |
|
$-44.08M |
|
116.28M |
|
| Cash Flow Statement Financials | |
$-1.74M |
|
-- |
|
$3.40M |
|
$0.02M |
|
$1.68M |
|
$1.66M |
|
$2.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-0.01 |
|
-0.21 |
|
-218.89% |
|
-30748.75% |
|
-30748.75% |
|
-- |
|
41001.85% |
|
44564.14% |
|
$-1.74M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.28 |
|
0.40 |
|
227.46 |
|
-19.25% |
|
-9.73% |
|
18.48% |
|
-19.49% |
|
$-0.38 |
|
$-0.01 |
|
$-0.01 |
|